John F. Sheridan - Nov 29, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
PRESIDENT & CEO, Director
Signature
s/ David B. Berger , Attorney-in-Fact for John F. Sheridan
Stock symbol
TNDM
Transactions as of
Nov 29, 2021
Transactions value $
-$52,772
Form type
4
Date filed
12/1/2021, 06:42 PM
Previous filing
Aug 31, 2021
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +820 +12.41% $0.00 7.43K Nov 29, 2021 Direct
transaction TNDM Common Stock Tax liability -$52.8K -407 -5.48% $129.66 7.02K Nov 29, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 +820 +11.12% $0.00 8.2K Nov 29, 2021 Common Stock 820 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).
F3 Each RSU represents a contingent right to receive one share of common stock of the Company.
F4 RSU vested as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.